Open AccessIron deficiency anaemia in pregnancy and its correction
Author(s) -
O.V. Vavina,
Т. К. Пучко,
М. А. Умралиева
Publication year - 2018
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2018-13-73-76
Subject(s) - medicine , pregnancy , miscarriage , obstetrics , iron deficiency , low birth weight , childbirth , premature birth , preeclampsia , birth weight , anemia , pediatrics , gestation , genetics , biology
The frequency of anaemia in pregnant women varies from 15 to 30%, iron deficiency anaemia (IDA) is the most common disorder, it accounts for about 90% of all anaemia. Iron deficiency adversely affects the course of pregnancy, childbirth, the postpartum period, the condition of the fetus and the newborn. The main complications of pregnancy in IDA are threatened miscarriage (20–42%); preeclampsia (40%); premature separation of placenta (25–35%); intrauterine growth restriction (25%); premature birth (11–42%). Daily intake of iron-containing drugs is more effective in preventing anaemia in mothers, and in reducing the risk of giving birth to children with low body weight. Daily iron supplementation in preventive programs may reduce the risk of anaemia in the mother at the time of delivery by 70%. It is preferable to take supplements that contain bivalent iron and possess a high degree of absorption, good tolerance by patients and minimal risk of side effects. Complex supplements containing vitamins and microelements are recommended for the treatment and prevention of IDA in pregnant women. Sorbifer Durules is one of such supplements. The Sorbifer Durules therapy of IDA in pregnant is highly effective treatment of therapy, which leads to normalization of hemogram parameters, improvement of the general condition of patients, reduction of obstetric and neonatal complications.